Background/Aims: Cholecystectomy is considered the treatment of choice for symptomatic gallstone disease. Some patients abstain from surgery and provide the opportunity to study the natural history of cholelithiasis. The aim of the present study was to examine the feasibility and safety of observation after extended long-term follow-up in a randomized controlled trial. Methods: A total of 137 patients (40.5% of those assessed) were randomized to observation or cholecystectomy and followed up for 14 years. The prevalence of symptomatic events or major complications after treatment was the primary end point. A secondary end point was completion of randomized treatment. Results: There were no differences in outcome between the observation group and the surgical group (p = 0.298). Virtually no cholecystectomy was performed after 5 years of follow-up, and no clear escalation in the severity of the disease was observed. A total of 50.7% of patients from the observation group and 88.2% from the surgical group underwent surgery. The group randomized to surgery completed their designated treatment significantly more often (p < 0.001), especially among patients younger than 70 years of age (p = 0.005). Conclusion: Cholecystectomy was the preferred treatment after extended long-term follow-up, but conservative management for symptomatic gallstone disease is an alternative to surgery in the elderly.

Keywords:
Gallstones, Cholecystectomy, Observation, Natural history
1.
Friedman GD, Raviola CA, Fireman B: Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 1989;42:127–136.
2.
Gracie WA, Ransohoff DF: Natural history and expectant management of gallstone disease; in Cohen S, Soloway RD (eds): Gallstones. New York, Churchill Livingstone, 1985, pp 27–43.
3.
Vetrhus M, Soreide O, Solhaug JH, Nesvik I, Sondenaa K: Symptomatic, non-complicated gallbladder stone disease. Operation or observation? A randomized clinical study. Scand J Gastroenterol 2002;37:834–839.
4.
Vetrhus M, Berhane T, Soreide O, Sondenaa K: Pain persists in many patients five years after removal of the gallbladder: observations from two randomized controlled trials of symptomatic, noncomplicated gallstone disease and acute cholecystitis. J Gastrointest Surg 2005;9:826–831.
5.
Vetrhus M, Soreide O, Eide GE, Solhaug JH, Nesvik I, Sondenaa K: Pain and quality of life in patients with symptomatic, non-complicated gallbladder stones: results of a randomized controlled trial. Scand J Gastroenterol 2004;39:270–276.
6.
Andersen PK, Gill RD: Cox’s regression model for counting processes: a large sample study. Ann Stat 1982;10:1100–1120.
7.
Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163–170.
8.
Lydersen S, Fagerland MW, Laake P: Recommended tests for association in 2 × 2 tables. Stat Med 2009;28:1159–1175.
9.
Mjaaland O, Høgevold H, Buanes T: Standard preoperative assessment can improve outcome after cholecystectomy. Eur J Surg 2000;166:129–135.
10.
Mertens MC, De Vries J, Scholtes VP, Jansen P, Roukema JA: Prospective 6 weeks follow-up post-cholecystectomy: the predictive value of pre-operative symptoms. J Gastrointest Surg 2009;13:304–311.
11.
Halldestam I, Kullman E, Borch K: Defined indications for elective cholecystectomy for gallstone disease. Br J Surg 2008;95:620–626.
12.
McSherry CK, Ferstenberg H, Calhoun WF, Lahman E, Virshup M: The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg 1985;202:59–63.
13.
Strasberg SM: Laparoscopic biliary surgery. Gastroenterol Clin North Am 1999;28:117–132.
14.
Heritier SR, Gebski VJ, Keech AC: Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust 2003;179:438–440.
15.
Salman B, Yuksel O, Irkorucu O, Akyurek N, Tezcaner T, Dogan I, Erdem O, Tatlicioglu E: Urgent laparoscopic cholecystectomy is the best management for biliary colic. A prospective randomized study of 75 cases. Dig Surg 2005;22:95–99.
16.
Trowbridge RL, Rutkowski NK, Shojania KG: Does this patient have acute cholecystitis? JAMA 2003;289:80–86.
17.
Rutledge D, Jones D, Rege R: Consequences of delay in surgical treatment of biliary disease. Am J Surg 2000;180:466–469.
18.
Konsten J, Gouma DJ, von Meyenfeldt MF, Menheere P: Long-term follow-up after open cholecystectomy. Br J Surg 1993;80:100–102.
19.
Sand J, Pakkala S, Nordback I: Twenty to thirty year follow-up after cholecystectomy. Hepatogastroenterology 1996;43:534–537.
20.
Wenckert A, Robertson B: The natural course of gallstone disease: eleven-year review of 781 nonoperated cases. Gastroenterology 1966;50:376–381.
21.
Lund J: Surgical indications in cholelithiasis: prophylactic cholelithiasis: prophylactic cholecystectomy elucidated on the basis of long-term follow up on 526 nonoperated cases. Ann Surg 1960;151:153–162.
22.
Friedman GD: Natural history of asymptomatic and symptomatic gallstones. Am J Surg 1993;165:399–404.
23.
Newman HF, Northup JD, Rosenblum M, Abrams H: Complications of cholelithiasis. Am J Gastroenterol 1968;50:476–496.
24.
Sobolev B, Mercer D, Brown P, FitzGerald M, Jalink D, Shaw R: Risk of emergency admission while awaiting elective cholecystectomy. CMAJ 2003;169:662–665.
25.
Attili AF, De Santis A, Capri R, Repice AM, Maselli S: The natural history of gallstones: the GREPCO experience. The GREPCO Group. Hepatology 1995;21:655–660.
26.
Randi G, Franceschi S, La Vecchia C: Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006;118:1591–1602.
27.
Cancer Registry of Norway: Cancer in Norway 2008 – cancer incidence, mortality, survival and prevalence in Norway. Oslo, Cancer Registry of Norway, 2009.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.